Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2005
08/24/2005CN1657061A Application of drug prescription of erigeron breviscapus aglucon in preparation of medicine
08/24/2005CN1657055A Traditional Chinese oral preparation of ophiopogon and coptisine and its preparation method
08/24/2005CN1657054A Oral administration dual polysaccharide Chinese medicine and its preparation method
08/24/2005CN1657053A Anti-coagulation and antiembolus function of EGP
08/24/2005CN1657052A Anti-coagulation and antiembolus function of CMSVPEP
08/24/2005CN1657051A Anti-coagulation and antiembolus function of yanzizhang polysaccharide
08/24/2005CN1657050A Chinese medicine oral preparation for lonering blood sugar and its preparation method
08/24/2005CN1657049A Cyclophosphamide compound preparation coataining glycyrrhizin
08/24/2005CN1657048A Laminaran granule and its preparation technology
08/24/2005CN1657047A Formula of calebassine dripping pills and its preparation method
08/24/2005CN1657046A Powder injection composed of sodium cefoperazone and potassium clavulanate
08/24/2005CN1657045A Antibacterial medicinal composite containing bota-lactanase inhibitor
08/24/2005CN1657044A Chlorretadin oral disintegrating tablet and its preparation method
08/24/2005CN1657043A Formula of lianbizhi preparation and its preparation method
08/24/2005CN1657042A Application of erigeron breviscapus aglucon in preparating medicine
08/24/2005CN1657041A Skin penetration absorption preparation
08/24/2005CN1657040A Curcumin and phosphatide composite and its preparation method
08/24/2005CN1656931A Health-care food containing ganoderma polysaccharide and tea polyphenol
08/24/2005CN1216078C Production process and application of marine sulfate polysaccharide
08/24/2005CN1216062C Nucleotide analog composation
08/24/2005CN1216056C Sulfamato hydroxamic acid metalloprotease inhibitor
08/24/2005CN1216055C Paroxetine hydrochloride anhydrous compound and its preparation method and use
08/24/2005CN1216054C 1,4-dihydro pyridine-3,5-carboxylic-acid derivatives and preparation method thereof
08/24/2005CN1216053C 2,2-disubstituted 1,3-dioxolanes as antitussive atents
08/24/2005CN1216052C Anti-neurodegeneratively active 10-aminoaliphatyl-dibenz (b,f) oxepines
08/24/2005CN1216051C Macrocyclic analogs and method of their use and preparation
08/24/2005CN1216047C Tricyclic lactam and sultam derivatives and their use as histone deacetylase inhibitors
08/24/2005CN1216034C Malic acid addition salts of terbinafine
08/24/2005CN1216018C Method of preparing surface-active alcohols and surface-active alcoholic ethers, products obtained by said method and their use
08/24/2005CN1215879C 人类sars冠状病毒受体抑制剂 Human sars coronavirus receptor inhibitors
08/24/2005CN1215876C Antigout medicinal composition and its preparing method
08/24/2005CN1215860C Compsn. for health-care of teeth and curing oral disease and its preparation method and application
08/24/2005CN1215849C Method for preparing baicalin liquid
08/24/2005CN1215848C Freeze-dried powder injection made from total flavone of may tree leaf
08/24/2005CN1215847C Control released osmotic pump prepn containing ligustrazine phosphate and its prepn
08/24/2005CN1215846C Use of 2a, 23-dihydroxyl ursolic acid in preparing the anti-inflammatory agent
08/24/2005CN1215845C Sustained releasing minipills of diltiazem hydrochloride and its preparation method
08/24/2005CN1215844C Gatifloxacin gels for eye and its preparing method
08/24/2005CN1215843C 黄藤素粉针剂 Palmatine powder
08/24/2005CN1215842C Use of atropin in preparation of drug-relief medicine
08/24/2005CN1215841C Prepn. method for injection of ginkgolide
08/24/2005CN1215840C Use of catechin in preparing medication for preventing and / or treating pancytopenia
08/24/2005CN1215839C Nano granules of solid lipid of tanshinone and its preparation method
08/24/2005CN1215838C Declofenac sodium pastes and preparation thereof
08/24/2005CN1215837C Ibuprofen solutions for capsule-filling and capsule preparations
08/24/2005CN1215836C Injection sotalol hydrochloride and preparation method thereof
08/24/2005CN1215834C Emulsion of perfluororganic compounds for medical purposes, method for producing said emulsion and methods for curing and preventing diseases with the aid of the emulsion
08/24/2005CN1215833C Rapidly disintegrating methylcellulose tablets
08/24/2005CN1215832C 气雾剂组合物 Aerosol composition
08/24/2005CN1215828C Synergistic antiplaque/antigivitis oral composition
08/24/2005CN1215768C Active ingredient compositions having insecticidal and acaricidal properties
08/24/2005CN1215765C Hydroxystilbene compounds used as microbicidal active substances
08/24/2005CN1215763C Alcohol-containing anti-microbial compositions with cosmetic apparatus
08/23/2005US6934639 Using the three-dimensional structure of human collagenase-3 (MMP-13), a member of the matrix metalloproteinase (MMP) for drug design of MMP-13 inhibitors
08/23/2005US6933396 Process to prepare psorospermin
08/23/2005US6933393 Reacting methyl cyanoacetate with morphiline to form 3-morpholin-4-yl-3-oxo- propionitrile; forming salt; reacting with phenylacetic acid and 2-(2-(4-fluorophenyl)-2-oxo-1-phenyl-ethyl)-4-
08/23/2005US6933392 Hydroxy substituted fused naphthyl-azoles and fused indeno-azoles and their use for the treatment of glaucoma
08/23/2005US6933389 Process for preparation of crystalline form-1 of pantoprazole sodium sesquihydrate
08/23/2005US6933387 Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indoles
08/23/2005US6933386 Process for preparing certain pyrrolotriazine compounds
08/23/2005US6933373 Tumor suppressor protein for as a antiproliferative agent
08/23/2005US6933372 Method to produce a solid form of heparin
08/23/2005US6933321 For therapy of androgen-dependent diseases such as prostate cancer, benign prostatic hyperplasia, precicious puberty, polycystic ovarian syndrome, acne, hirsutism, seborrhea, androgenic alopecia and premature male baldness
08/23/2005US6933320 Combination comprising combretastatin and anticancer agents
08/23/2005US6933318 Topical organic ectoparasiticidal formulations
08/23/2005US6933316 Indole compounds
08/23/2005US6933315 bis indole derivatives containing acetylated saccharide groups
08/23/2005US6933314 Integrin receptor inhibitors
08/23/2005US6933313 Carbazoles with hydroxyfunctional amide (hydroxamic or esters) are for inhibiting sPLA2 mediated release of fatty acids for treatment of conditions such as septic shock
08/23/2005US6933310 treating motor neuron diseases by administering 3-methyl-1-phenyl-2-pyrazoline-5-one or a salt thereof
08/23/2005US6933309 Halogenobenzyl aminopropionic acid derivatives
08/23/2005US6933306 Anticancer agents; antiinflammatory agents; autoimmune disease
08/23/2005US6933304 Antitumor agents, osteoporosis
08/23/2005US6933303 Antidiabetic agents
08/23/2005US6933301 1,2,3,6-tetrahydropyrimidine-2-one compositions, articles and therapeutic methods for upper airway breathing disorders
08/23/2005US6933300 JAK-3 inhibitors for treating allergic disorders
08/23/2005US6933299 Anilinoquinazolines as protein tyrosine kinase inhibitors
08/23/2005US6933297 7-chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione and the use thereof for the treatment of pain
08/23/2005US6933296 A 2H-pyridazine-1-one derivatives as bronchodilator agents for the treatment of asthma, chronic obstructive pulmonary disease, respiratory system disorders
08/23/2005US6933295 Substituted isoindoles and the use thereof
08/23/2005US6933293 Unit treatment dose and patient package
08/23/2005US6933292 Compositions of ezetimibe and methods for the treatment of cholesterol-associated benign and malignant tumors
08/23/2005US6933289 Mixture of bimatoprost, cyclodextrins and flow control agents such as sodium carboxymethylcellulose, having attenuated sensitivity
08/23/2005US6933288 Pyranosyl cytosines: pharmaceutical formulations and methods
08/23/2005US6933286 Therapeutic delivery compositions and methods of use thereof
08/23/2005US6933285 Flavin N-oxides: new anti-cancer agents and pathogen eradication agents
08/23/2005US6933281 Administering nonapeptides conjugated to drugs or labels, that preferentially targets the lungs, pancreas, skins, eyes, prostate galnds , ovaries, adrenal gland, liver or alimentary canal; drug delivery; medical diagnosis
08/23/2005US6933272 Administering compounds such as 4,4'-Methylenebis[3-hydroxy-2-naphthalenecarboxylic acid], as hypoglycemic or antidiabetic agents; receptor modulators
08/23/2005US6933271 Aimed at neoplastic cells with gonadotropin releasing hormone binding sites; anticarcinogenic agents; genetically engineered Pseudomonas Exotoxin
08/23/2005US6933148 Cell separation compositions and methods
08/23/2005US6933116 Nucleic acid ligand binding site identification
08/23/2005US6933113 Modulation of endogenous gene expression in cells
08/23/2005US6933107 For inhibition of cholesterol absorption
08/23/2005US6933104 administration of catalytic iron chelator compound, then urine screening for creatinine levels
08/23/2005US6932988 Comprises brewing black pekoe tea, then adding aspirin tablets, apple cider vinegar, and honey
08/23/2005US6932987 A chemical formulation which enhances metabolism, is formed into tablets, each of such tablets containing L-carnitine; conjugated linoleic acid, Citrus aurantium; ginger extract, green tea extract,and capsaicin
08/23/2005US6932984 Method of microencapsulation
08/23/2005US6932977 Method of inducing or enhancing chondrogenesis with extracellular matrix containing BMP-4
08/23/2005US6932974 Sterile barrier
08/23/2005US6932963 Treatment of skin wounds using polyenylphosphatidylcholine and alkanolamines